This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …

In this review, we especially cover the following themes: new clinical studies on the use of
MTX in RA, the use of MTX in other rheumatic conditions, prediction of response to MTX …

This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …

Low-dose methotrexate (MTX) remains the first-line treatment option among the disease-
modifying antirheumatic drugs in patients with rheumatoid arthritis. However, diverse side …

La psoriasis es una enfermedad de filiación inmunológica, frecuente a nivel mundial. En
población europea y en EE. UU. reporta una prevalencia del 0, 6 al 4%. No hay reportes en …

Children with leukemia treated with methotrexate (MTX) may develop MTX-induced
leukoencephalopathy, which can present as seizures or focal neurological deficits …

Methotrexate is a folic acid analog with a favorable efficacy-to-toxicity ratio that has been
used for many years to treat a variety of inflammatory arthropathies, thereby explaining the …

The first patient, a 57-year-old African-American female with a 1-year history of seropositive
rheumatoid arthritis (RA), presented to the pulmonology clinic with increasing shortness of …

Beim Verfassen dieser Leitlinie haben die Autoren* innen auf einer Vorversion (vor dem
Peer Review) der folgenden Publikation aufgebaut und diese außerdem adaptiert, neu …

A 71-year-old right-handed man presented with a 3-month history of progressive cognitive
impairment. Six weeks before presentation, he became unable to use his mobile phone, with …